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Abstract The hemocytes of the freshwater snail Viviparus ater 
have nitric oxide synthase (NOS) activity, as demonstrated by 
[3H]citrulline and nitrite+nitrate formation. The enzyme is 
NADPH dependent and is competitively inhibited by the mam- 
malian NOS inhibitor NG-monomethyI-L-arginine (K i = 4.7 
/tM). The K m for L-arginine is 2.5/tM. 70% of the total activity 
is observed at very low free Ca 2÷ concentration (3 nM). LPS 
treatment increased total NOS activity 2.4 fold. The activity is 
partly present in the non-soluble fraction of hemocytes (24% and 
8% in non-stimulated and LPS-stimulated snails, respectively). 
An antiserum to the C-terminal synthetic pentadecapeptide of the 
rat cerebellar NOS inhibited the enzyme activity in a concentra- 
tion-dependent manner. This is the first biochemical demonstra- 
tion of the existance of NOS activity in molluscan hemocytes, the 
cells responsible for defence mechanisms. 
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I. Introduction 
Nitric oxide (NO) is a molecular messenger with numerous 
functions, including regulation of vascular tone, cellular signal- 
ing in the brain, and the elimination of pathogens in a non- 
specific immune response [1-3]. Different NO synthase (NOS) 
isozymes have been purified from various mammalian tissues 
[4,5]. Three major isoforms have been cloned: a CaZ÷/calmod - 
ulin-dependent, cytosolic enzyme from the brain [6-9], an in- 
ducible, Ca2÷-independent NOS from activated macrophages 
[10,11], and a CaZ+-dependent membrane-associated isoform 
from vascular endothelial cells [12,13]. However, some data 
suggest that there are more than three isoforms. Indeed, hepa- 
tocyte, chondrocyte and neutrophile NOS have peculiar prop- 
erties [4,14,15]. The NOS so far characterized are all NADPH- 
dependent and require several co-factors: H4biopterin (BH4), 
FAD and FMN [10,11,16-19]. Both neuronal and inducible 
NOS are P450-type heme proteins [20-23]. NOS isozymes cata- 
lyze a two-step, monooxygenase-like oxidation of L-arginine 
[24] by means of an NADPH-dependent reductive activation of 
molecular oxygen [16] which is incorporated into both NO and 
L-citrulline [25,26]. At non-saturating concentrations of L- 
arginine and BH4, oxygen activation catalyzed by the brain 
enzyme does not result in NO synthesis, but rather leads to the 
production of the superoxide anion and H202 [24]. 
NOS has been characterized from rodent, bovine or porcine 
tissue, as well as from several human cells, such as neutrophils, 
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HL-60 cells and platelets [27,28]. The various NOS isoenzymes 
are very different from amino acid sequences, while the same 
isoenzyme is well conserved between mammalian species, sug- 
gesting either that the differentiation of the isoenzymes takes 
place before the evolution of mammalian species, or that the 
functional and structural differentiation between the various 
NOS isoenzymes is so high that no further major variability in 
the sequence is allowed. 
Few data available on the NOS of non-mammalian animals. 
In the last few years, NOS activity has been shown to be present 
in the central nervous ystem of many advanced invertebrate 
phyla (annelids, arthropods and molluscs) [29,30]. Evidence for 
NOS activity in invertebrate h mocytes has been obtained by 
Radomski et al. [31] and Ottaviani and co-workers [32,33]. The 
study of NOS in invertebrates is a very useful way of under- 
standing the evolution and the reaction mechanisms of the NOS 
isoforms, since many similarities between invertebrate and ver- 
tebrate immune/defence systems have been reported, suggest- 
ing that the origin of this system, as well as that of the nervous 
system, can be traced back to invertebrates [34,35]. To our 
knowledge, the present study is the first biochemical demon- 
stration of the existence of NOS activity in molluscan he- 
mocytes, indicating that this enzyme may have appeared very 
early in evolution and play an essential role in defence systems. 
2. Materials and methods 
2.1. Reagents 
(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride was purchased 
from Dr. B. Schircks Laboratories (Jona, Switzerland) and L-[2,3,4,5- 
3H]arginine monohydrochloride (58 Ci/mmol) from Amersham (Buck- 
inghamshire, England). The protein dye reagent and the ion-exchange 
resin AG50WX-8 were supplied by Bio-Rad (Milano, Italy), and calm- 
odulin, glucose-6-phosphate dehydrogenase from yeast (EC 1.1.I.49) 
and glucose-6-phosphate by Serva (Heidelberg, Germany). Nitrate re- 
ductase fiom Aspergillus pp. (EC 1.6.6.2), lipopolysaccharide (LPS) 
from Escherichia coli, NG-monomethyl-L-arginine (L-NMMA) and all 
other biochemicals were obtained from Sigma (Milano, Italy) and the 
anti-NOS polyclonal antiserum from Euro-Diagnostica (Ferring 
group, Sweden). 
2.2. Snails 
Adult specimens of Viviparus ater were collected ina freshwater canal 
near Modena (Italy) in spring and early summer. The animals were 
maintained atroom temperature in dechlorinated freshwater for at least 
a week before xperiments. Snail hemolymph was obtained by prodding 
the animal's loot and collected with a Pasteur pipette. Hemocytes were 
obtained by centrifugation at 600 x g. The cells were washed twice with 
snail saline solution [36], counted and collected by centrifugation. I  
order to evaluate he induced NOS activity, the snails were injected with 
20/tg of LPS (4 U//~I) and hemolymph was collected 4 h after injection. 
2.3. Determination of NOS activity 
Hemocytes were homogenized with Ultra-Turrax (IKA-WERK, 
Germany) in 5 vols. of ice-cold solution containing 320 mM sucrose, 
50raM Tris, 1 mM EDTA, 1 mM dithiothreitol (DTT), 1 mM 
phenylmethylsulphonyl fluoride, 10/lg/ml soybean trypsin inhibitor, 
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10 pg/ml antipain and 10 pg/ml bestatin brought to pH 7.0 at 20°C with 
HC1. The homogenate was centrifuged at 20,000 × g for 30 min at 4 ° C, 
and the supernatant was freed from low molecular mass compounds by 
Sephadex G-25 chromatography [37]. The protein fraction was eluted 
with a buffer containing 50 mM HEPES, pH 7.4, 1 mM EDTA, 1 mM 
DTT and the indicated above protease inhibitors. 
NOS activity was assayed by following the conversion of radiola- 
beled arginine to citrulline. Standard reaction mixtures contained 50 
mM HEPES, pH 7.4, 0.5 mM EDTA, 1.4 mM CaCI2, 1 mM MgCI2, 
1 mM NADPH, 1 mM DTT, 12 mM L-valine, 1 mM citrulline, a 
variable amount of e-arginine, 80,000-100,000 cpm of purified L- 
[2,3,4,5-3H]arginine monohydrochloride and 5-50/tl of Sephadex G-25 
eluate in a finale volume of 100 pl. 
After 30 min incubation at 37°C, [3H]citrulline was quantified by 
liquid scintillation counting after separation from [3H]arginine by cat- 
ion exchange (AG50WX-8) [38]. The Na ÷ form of AG50WX-8 was 
prepared by washing the +H form of the resin with 1 M NaOH 4 times 
and then washing with H20 until the pH was less than 7.5. 
As reported by Bredt and Snyder [38], with thin layer chromatogra- 
phy, more than 95% of the radioactivity in the water eluates from 
AG50WX-8 columns, rechromatographed with three different solvents 
on Whatman o. 1 paper at 18°C, migrates as the authentic L-citrulline 
standard [39]. The solvents utilized as the mobile phase were: 
phenol :water :ammonia d 0.88 (160:40 : 1, w/v/v), methanol : water: 
pyridine (20:5:1) and n-butanol:pyridine:water ( l :1: 1). 
The total NOS (CaZ+-dependent a d CaZ+-independent ac ivity) was 
determined by calculating the difference between the [3H]citrulline pro- 
duced in the presence and in the absence of 10 mM NG-monomethyl-L- 
arginine (L-NMMA, an inhibitor of mammalian NOS) in standard 
reaction mixture. To evaluate the Ca2+-independence a tivity, 6 mM 
EGTA was added to the standard assay mixture (free calcium concen- 
tration 20 nM). In some experiments, 6 mM EGTA was added to the 
standard mixture which contained 0.25 mM CaCI2 instead of 1.4 mM 
CaCI2 for 3 nM free Ca 2+ concentration. The free calcium concentration 
was calculated following Fabiato [40]. Enzyme activity is given as pmol 
of [3H]citrulline formed per min for each mg of protein in the cell 
extract. 
L-[3H]Arginine was purified by adding the radiolabel to 20 mM 
HEPES (2 ml), pH 5.5, to a 1 ml column of AG50WX-8 resin (prepared 
as above), washing the column with 8 ml of H20 and eluting with 4 ml 
of 0.5 M ammonia. The eluate was freeze-dried and resuspended in 2% 
ethanol [41]. 
To determine the stoichiometry of nitrine + nitrate and citrulline, the 
standard reaction mixture was supplemented with an NADPH regener- 
ating system (0.25 unit/ml glucose-6-phosphate dehydrogenase and 
20 mM glucose-6-phosphate), and the incubation time was prolonged 
up to 3 h at 37°C. For nitrite + nitrate determination, itrate was re- 
duced by nitrate reductase (1.25 units/ml) in the presence of 2.5 mM 
NADPH for 1 h at room temperature [37]. Nitrite was determined 
according to Green et al. [42]. 
Formation of [3H]citrulline and NO was linear with time for up to 
1 h in the standard assay and for up to 3 h in the assay supplemented 
with an NADPH regenerating system. The NOS activity of the non- 
soluble fraction was determined by washing the hemocyte pellet twice 
with PBS, centrifuging at20,000 x g for 30 rain at 4°C and resuspending 
with the buffer used for Sephadex G-25 chromatography. Activity was 
calculated by the radiochemical method and expressed as pmol of 
[3H]citrulline formed/mini106 cells. 
Protein in cell extracts was determined according to Bradford [43], 
with BSA as standard. With the standard assay, the velocity was linear 
up to 10 pg of the total cell protein of the LPS stimulated snails. With 
25 pM L-arginine, linearity was evident up to 150 pg/protein. The 
results obtained are expressed as means + S.D. of at least four inde- 
pendent experiments performed in triplicate. 
3. Results 
Table I shows the formation of [3H]citrulline and ni- 
trite + nitrate in relation to incubation time, utilizing 
standard reaction mixtures containing 25 pM L-arginine and 
the NADPH regenerating system with and without 10 mM N G- 
monomethyl-L-arginine. L-Citrulline and NO were formed in 
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Fig. 1. Concentration-dependent inhibition of hemocyte NOS activity 
by L-NMMA in the presence of 1 pM [3H]arginine. Data are expressed 
as percent inhibition of control (40.1 + 3.2 pmol. min-I .mg protein-l). 
Each point is the mean of four independent experiments. 
equimolar concentrations as a function of incubation time, 
suggesting that NOS activity is present in V. ater hemocytes. 
[3H]Citrulline formation decreases with increasing concen- 
trations of the NOS inhibitor NG-monomethyl-e-arginine 
(Fig. 1). With 1 mM L-NMMA, almost complete inhibit ion was 
obtained (enzyme activity lower than 1%) at 1/.tM substrate, 
whereas 4-5% of residual activity was maintained at 25 pM 
L-arginine. Thus, when substrate concentrat ion was higher than 
5/.tM, L -NMMA concentrat ion i creased to 10 mM. 
Fig. 2 reports the enzyme activity as a function of L-arginine 
concentration. In the same figure, NOS activity in the presence 
of two different concentrat ions of L -NMMA (2 pM and 6 pM)  
is also shown. Inhibit ion appears to be competitive for L-argin- 
ine. The K m and K i for L-arginine and L -NMMA are 
2 .5+0.6pM and 4 .7+ 1.1 pM,  respectively. A Vmax of 
125.0 + 8.0 pmol -min -~'mg -~ was obtained with LPS stimu- 
lated hemocytes. 
We also tested the inhibit ion of NOS activity in hemocyte 
extract with rabbit polyclonal antiserum to the C-terminal syn- 
thetic pentadecapeptide, F IEESKKDADEVFSS,  of the rat 
cerebellar NOS [44]. As indicated in Table 2, NOS activity falls 
to 40% of the control in the presence of rabbit  antiserum diluted 
1 : 8. The inhibitory effect of the antiserum depends on dilution: 
with 1:40 and 1:400 dilutions, NOS activity decreases to 51% 
and 91% of the control. This effect is not seen with non- immune 
rabbit serum. 
Table 3 shows the effect on [3H]citrulline formation of the 
omission or addit ion of various co-factors. Whereas the omis- 
Table 1 
NOS activity in 14 ater hemocytes: toichiometric [3H]citrulline and 
nitrite + nitrate formation 
Time of incubation [3H]Citrulline Nitrite _+ nitrate 
(min) (nmol" mg protein ~) (nmol. mg protein -1) 
60 6.7 + 0.3 6.3 _+ 0.4 
120 12.9 + 0.5 13.2 + 0.6 
180 18.4 + 0.8 18.9 _+ 1.1 
Standard reaction mixtures containing 25 pM L-arginine and the 
NADPH regenerating system with or without 10 mM L-NMMA were 
prepared as detailed in section 2. Values are means + S.D. of four 
independent experiments performed in triplicate. 
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Table 2 
Inhibition of 14 ater hemocyte NOS activity by rabbit antiserum tothe 
C-terminal synthetic pentadecapeptide of the rat cerebellar NOS 
Antibody and dilution [3H]Citrulline 
(pmol-min -1.mg protein ~ )
Control 
Anti-NOS (1:8) 
Anti-NOS (1:40) 
Anti-NOS (1:400) 
Rabbit non-immune s rum (1:8) 
42.3 + 3.7 
16.8 + 1.9 (39.7%) 
21.5 _+ 2.5 (50.8%) 
38.7 + 3.6 (91.5%) 
41.2 + 4.3 
A rabbit antiserum toNOS was included in standard reaction mixtures 
prepared as detailed in section 2, without substrate. After 5 min of 
incubation at 37°C, the reaction was started with 1 /IM substrate. 
Values are means + S.D. of four independent experiments performed 
in triplicate. 
sion of NADPH decreases NOS activity to 35%, the adddition 
of FAD, FMN, BH4 or calmodulin in the standard reaction 
mixture does not produce significant variations in [3H]citrulline 
formation. NOS activity is significantly reduced by the addition 
of 6 mM EGTA, which decreases the free Ca 2 + concentration 
to about 20 nM. The fall in the free Ca 2 + concentration to
about 3 nM does not further decrease the enzyme activity. The 
omission of Mg 2+ results in no significant variation in [3H]cit- 
rulline formation with respect o the control. 
Table 4 presents the distribution of NOS activity in the solu- 
ble fraction and the pellet of LPS-stimulated and non-stimu- 
lated hemocytes. Stimulation with LPS increases the total NOS 
activity 2.4 fold. However, NOS activity in the pellet of LPS- 
stimulated cells does not rise, meaning that the distribution of 
activity between the soluble and pellet fractions varies consider- 
ably in non-stimulated (24% in the pellet) and LPS-stimulated 
hemocytes (8% in the pellet). 
4. Discussion 
Our results how that V. ater hemocytes present NOS activity 
comparable to that observed in mammalian cells. This is dem- 
onstrated by the strict relationship between [3H]citrulline and 
nitrite + nitrate formation, by the inhibition of the reaction 
with the competitive inhibitor N6-monomethyl-L-arginine and 
by the need for NADPH to provoke the full activity of the 
enzyme. Furthermore, a NOS polyclonal rabbit antiserum pro- 
duced a concentration-dependent inhibition of the snail enzyme 
activity. The observed values of Km for L-arginine and K i for 
Table 3 
Effect of some cofactors on 14 ater hemocyte NOS activity 
Conditions [3H]Citrulline 
(pmol. min -~ .mg protein -~) 
Standard 39.4 + 4.1 
NADPH omitted 13.8 + 2.0 
BH 4 (10/IM) 37.1 + 3.9 
Calmodulin (50/lg/ml) 39.9 + 4.2 
FAD (10/.tM) 36.4 + 3.7 
FMN (10//M) 38.7 + 3.7 
BH4, FAD, FMN, (10 ,uM each) 35.9 + 4.0 
Ca 2+ (<3 nM) 28.6 + 4.5 
Ca 2÷ (_<20 nM) 29.8 + 6.2 
Mg 2÷ omitted 37.7 + 3.9 
Standard reaction mixtures containing I/IM L-arginine were prepared 
as detailed in section 2. Values are means _+ S.D. of four independent 
experiments performed in triplicate. 
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Fig. 2. L-Arginine concentration dependence of I4 ater hemocyte NOS 
activity. The assay was performed using standard reaction mixtures 
with different amounts of L-arginine. [3H]Citrulline formation in the 
presence of 2~tM (©) and 6/tM ([]) L-NMMA is also reported. Each 
point is the mean of four independent experiments. 
L-NMMA were comparable to those seen in mammalian cell 
enzymes. 
After removal of low molecular mass compounds by Se- 
phadex G-25 chromatography, the NOS activity in the protein 
fraction did not increase when BH4, flavins or calmodulin were 
added to the standard reaction mixture. It seems, however, 
unlikely that hemocyte NOS activity is dependent of these fac- 
tors, which may be present in the Sephadex G-25 eluate in 
sufficient quantity to maximise nzyme activity. It should be 
noted that sometimes these factors remain bound to the protein 
fraction even after extensive purification of mammalian NOS 
[16,18,19]. This may also be the case for snail NOS, but further 
studies and a better characterization f the enzyme are needed 
to clarify this question. 
Hemocyte NOS activity is significantly decreased at very low 
free calcium concentrations, but nevertheless more than 70% 
of the enzyme activity remains. In this respect, the Ca 2 +-de- 
pendence of hemocyte NOS is similar to that of an inducible 
form of human hepatocyte NOS cloned by Geller et al. [14]. It 
has been suggested that this form, which is present in a wide 
range of tissues, may be a primitive, non-specific defence system 
against any type of invading organism. 
The LPS stimulated snail hemocytes showed only a 2 3 fold 
increase in enzyme activity, while in stimulated mammalian 
cells a much more considerable rise in NOS activity was ob- 
served. It is possible that the non-LPS-treated snails were in a 
partially stimulated condition, given that they were collected 
from a wild environment and maintained in non-sterile water, 
and the hemocytes are the snail's most important defence sys- 
tem [45,46]. Also, LPS may not be the most effective inducible 
compound, as observed in some mammalian cells, in which 
greater esponses have been obtained when combining two 
stimulating agents. It is further conceivable that there are two 
different isoforms, constitutive and inducible NOS, in these 
cells. 
It should be noted that the NOS activity is inactivated by an 
antiserum obtained using the C-terminal synthetic pentade- 
capeptide of the rat cerebellar NOS isoenzyme as immunogen. 
This sequence is quite different in the various mammalian 
isoenzymes. Only 3, 8 or 3 amino acid residues appear to be 
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Table 4 
Hemocyte NOS activity in the soluble fraction and in the pellet of LPS 
stimulated and non-stimulated V. ater snails 
[3H]Citrulline 
(pmol. min -t. 106 cells i) 
Non-stimulated LPS stimulated 
Supernatant 47.9 + 6.6 138.7 + 15.1 
Pellet 15.5 + 4.8 12.3 + 3.2 
Total 63.4 151.0 
Standard reaction mixtures containing 1/IM L-arginine were prepared 
as detailed in section 2. Values are means + S.D. of four independent 
experiments performed in triplicate. 
conserved in macrophage, hepatocyte and endothelial NOS, 
respectively, compared to rat cerebellar enzyme. Non of the 
fifteen amino acid residues appears in the same position in the 
four isoforms o far cloned, and no specific functions have been 
attributed to this C-terminal sequence. Nevertheless it would 
seem that a crossreactivity is still present between C-terminal 
sequences of rat cerebellar NOS and the NOS of the hemocytes 
of the V. ater snail. 
From this preliminary characterization f the NOS activity 
of hemocytes, it appears that, although the snail enzyme(s) 
shares properties with the different NOS, it can not be identi- 
fied with any of the enzymes o far studied and, in particular, 
not with the enzyme of mammalian phagocytic ells. It is in 
some ways similar to the hepatocyte isoenzyme studied by 
Geller et al. [14], which has been suggested to be a primitive 
non-specific defence system. However, further characterization 
is needed for a better evaluation of the similarities and the 
differences with respect o mammalian isoforms. 
The demonstration that NOS activity is present in hemocytes 
of V. ater is relevant not only to our knowledge of the develop- 
ment of non-specific immunitary defence systems, but also to 
the evolution of the isoforms, the differences in multiple cata- 
lytic functions [25] and the possible relationship between the 
signaling and defence roles of NO. In this respect, it should be 
pointed out that at non-saturating e-arginine or BH 4 concen- 
trations, the constitutive Ca2+/calmodulin-dependent NOS 
from rat brain, but not the inducible Ca2+-independent NOS 
from activated macrophages, catalyzes the formation of super- 
oxide anions and idrogen peroxide [25], two oxygen reactive 
species utilized by phagocytic ells to eliminate invading organ- 
isms. 
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